Abstract
Chemoradiotherapy for head and neck cancer has achieved remarkable progress in the past two decades. This progress has resulted in efforts to redefine the standard of care for patients with this disease. A brief review of the history of current chemoradiotherapy was conducted to clarify the rationale for this approach. An attempt was made to present problems that remain to be solved. The review showed that chemoradiotherapy for head and neck cancer is now becoming a vital treatment option for patients with advanced disease. Currently available and upcoming data are about to clarify important issues regarding proper patient selection, standard procedures, management of toxicities, ultimate cure, and quality of life. This newly developed and promising treatment option has, however, confounding problems to be solved. Meticulous collaboration in an experienced multidisciplinary team is required to address these problems and to spread this approach in daily clinical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
